.png)
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market by Type and Distribution Channel - Global Industry Analysis & Forecast to 2027
Published On : July 2020 Pages : 150 Category: Pharma & Healthcare Report Code : HC0711845
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market by Type (Aspirin, Ibuprofen, Naproxen, Celecoxib, Others) Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period Non-Steroidal Anti-Inflammatory Drugs reduce inflammation, and helps to relieve pain. They act by blocking prostaglandins, which are substances that sensitize your nerve endings and enhance pain during inflammation.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Merck & Co., Inc.
- Amgen Inc.
- Novartis AG
- AbbVie Inc.
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- Biogen
- Johnson & Johnson Services, Inc.
- Pfizer Inc.
- GlaxoSmithKline plc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Aspirin
o Ibuprofen
o Naproxen
o Celecoxib
o Others
· Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, By Distribution Channel, Estimates and Forecast, 2017-2027 ($Million)
o Hospital Pharmacy
o Retail Pharmacy
o Online Pharmacy
· Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Merck & Co., Inc.
o Amgen Inc.
o Novartis AG
o AbbVie Inc.
o Bristol-Myers Squibb Company
o Eli Lilly and Company
o Biogen
o Johnson & Johnson Services, Inc.
o Pfizer Inc.
o GlaxoSmithKline plc.
· Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Submarine Cables Market, By Country
o U.S. Submarine Cables Market
o Canada Submarine Cables Market
o Mexico Submarine Cables Market
o Europe
§ Europe Submarine Cables Market, By Country
o Germany Submarine Cables Market
o UK Submarine Cables Market
o France Submarine Cables Market
o Russia Submarine Cables Market
o Italy Submarine Cables Market
o Rest of Europe Submarine Cables Market
o Asia-Pacific
§ Asia-Pacific Submarine Cables Market, By Country
o China Submarine Cables Market
o Japan Submarine Cables Market
o South Korea Submarine Cables Market
o India Submarine Cables Market
o Southeast Asia Submarine Cables Market
o Rest of Asia-Pacific Submarine Cables Market
o South America
§ South America Submarine Cables Market
o Brazil Submarine Cables Market
o Argentina Submarine Cables Market
o Columbia Submarine Cables Market
o Rest of South America Submarine Cables Market
o Middle East and Africa
§ Middle East and Africa Submarine Cables Market
o Saudi Arabia Submarine Cables Market
o UAE Submarine Cables Market
o Egypt Submarine Cables Market
o Nigeria Submarine Cables Market
o South Africa Submarine Cables Market
o Rest of MEA Submarine Cables Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, By Type
5.1. Introduction
5.2. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Type (2017-2021)
5.2.1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Revenue Share by Type (2017-2021)
5.3. Aspirin
5.3.1. Global Aspirin Revenue and Growth Rate (2017-2021)
5.4. Ibuprofen
5.4.1. Global Ibuprofen Revenue and Growth Rate (2017-2021)
5.5. Naproxen
5.5.1. Global Naproxen Revenue and Growth Rate (2017-2021)
5.6. Celecoxib
5.6.1. Global Celecoxib Revenue and Growth Rate (2017-2021)
5.7. Others
5.7.1. Global Others Revenue and Growth Rate (2017-2021)
6. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, By Applications
6.1. Introduction
6.2. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Revenue Share by Applications (2017-2021)
6.3. Hospital Pharmacy
6.3.1. Global Hospital Pharmacy Revenue and Growth Rate (2017-2021)
6.4. Retail Pharmacy
6.4.1. Global Retail Pharmacy Revenue and Growth Rate (2017-2021)
6.5. Online Pharmacy
6.5.1. Global Online Pharmacy Revenue and Growth Rate (2017-2021)
7. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, By Region
7.1. Introduction
7.2. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Regions
7.2.1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Regions (2017-2021)
7.3. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Countries
7.3.1. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2021)
7.3.2. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Countries
7.4.1. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2021)
7.4.2. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Countries
7.5.1. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Countries
7.6.1. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2021)
7.6.2. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Countries
7.7.1. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Merck & Co., Inc.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Amgen Inc.
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Novartis AG
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. AbbVie Inc.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Bristol-Myers Squibb Company
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Eli Lilly and Company
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Biogen
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Johnson & Johnson Services, Inc.
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Pfizer Inc.
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. GlaxoSmithKline plc.
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Regions (2022-2027)
9.2.1. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.1.1. United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.1.2. Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.1.3. Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.2. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.2.1. Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.2.2. France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.2.3. UK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.2.4. Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.2.5. Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.3. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.3.1. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.3.2. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.3.3. Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.3.4. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.4. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.4.1. Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.4.2. Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.4.3. Columbia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.4.4. Rest of South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.5. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.5.3. Egypt Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.5.4. Nigeria Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.5.5. South Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.5.6. Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2022-2027)
9.3. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Type (2022-2027)
9.3.1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Type (2022-2027)
9.3.2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Type (2022-2027)
9.4. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Applications (2022-2027)
9.4.1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Applications (2022-2027)
9.4.2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Revenue Share by Type (2017-2019)
Figure Global Aspirin Revenue and Growth Rate (2017-2019)
Figure Global Ibuprofen Revenue and Growth Rate (2017-2019)
Figure Global Naproxen Revenue and Growth Rate (2017-2019)
Figure Global Celecoxib Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Revenue Share by Applications (2017-2019)
Figure Global Hospital Pharmacy Revenue and Growth Rate (2017-2019)
Figure Global Retail Pharmacy Revenue and Growth Rate (2017-2019)
Figure Global Online Pharmacy Revenue and Growth Rate (2017-2019)
Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Regions (2017-2019)
Figure North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2019)
Figure North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Countries (2017-2019)
Figure North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Countries (2017-2019)
Figure United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2019)
Figure Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Countries (2017-2019)
Figure Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Countries (2017-2019)
Figure Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure UK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Rest of Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Countries (2017-2019)
Figure Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Countries (2017-2019)
Figure China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2019)
Figure South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Countries (2017-2019)
Figure South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Columbia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Rest of South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Countries (2017-2019)
Figure Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure United Arab Emirates Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Egypt Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Nigeria Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure South Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2017-2019)
Table Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Financial Overview
Table Amgen Inc. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Financial Overview
Table Novartis AG Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Financial Overview
Table AbbVie Inc. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Financial Overview
Table Bristol-Myers Squibb Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Financial Overview
Table Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Financial Overview
Table Biogen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Financial Overview
Table Johnson & Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Financial Overview
Table Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Financial Overview
Table GlaxoSmithKline plc. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Financial Overview
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Millions USD) and Growth Rate (2019-2027)
Table Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Regions (2019-2027)
Figure North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure UK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Rest of Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Columbia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Rest of South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure United Arab Emirates Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Egypt Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Nigeria Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure South Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2019-2027)
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Type (2019-2027)
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Type (2019-2027)
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Type (2019-2027)
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Applications (2019-2027)
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Applications (2019-2027)
Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|